Computational science and technology company combining molecular simulation, artificial intelligence, and software engineering to explore life sciences.

Nairobi, Kenya
Joined October 2026
I highly recommend cloudflare's security audit skill: github.com/cloudflare/securi… Run it on all your software. Run it with the free models. Use it even if you used a model to audit something - it will find much more things. Works in all agent harnesses and is model independent.
132
755
47
8,720
602,786
🧬 Design proteins faster and send fewer, better candidates to the lab. Introducing RFD4-Proteina, a new NVIDIA BioNeMo open model co-developed with @UWproteindesign. ▫️Fast: 13× faster generation than RFdiffusion3 at 200 residues ▫️ Smart: state-of-the-art across 12+ protein design tasks ▫️ Programmable: set your design inputs and use test-time compute on harder problems Start with our binder-design tutorial nvda.ws/3VK9Uvr
7
60
10
204
17,487
Avengers assemble: 1 year BakerLab + NVIDIA GenAIR = 🔥 rfd4-proteina.org Presenting RFD4-Proteina, our latest protein design model, significantly better and faster than everything we compared against, both in silico and in the lab! 1/30
27
202
43
660
63,578
Most drugs work like a key in a lock. But hard-to-treat diseases often lack a lock to begin with, leaving them out of reach for conventional medicine. Covalent drugs change the game by bonding permanently to their targets. To find the right molecules, @ExpeditionMedicines fine-tuned the AIMNet2 model with the NVIDIA ALCHEMI Toolkit—screening 15 million structures per $1,000 of compute (17x faster and cheaper than GFN2-xTB). expeditionmedicines.com/news…
3
21
84
3,655
Challenge 4 of the Anthropic × Adaptyv Protein Design Competition on @proteinbase is open: design a pH-sensitive protein to help shuttle drugs into the brain. TfR1 is a receptor protein that brings iron-loaded transferrin into cells. It is highly expressed in the blood-brain barrier and drug developers can use this receptor to get drugs to pass the blood-brain barrier. The drug is fused to a binder to TfR1, which makes cells absorb the protein complex. If the binder is pH-sensitive it will release from the receptor inside the endosome and then exit the cells on the brain-facing side to deliver the therapeutic into the brain. In this challenge, the goal is to make a pH-sensitive binder to TfR1 that targets precisely the right region on the receptor in order to allow absorption into the cell.
4
12
2
53
5,726
Public preview of BioEmu2! @MSFTResearch AI for Science’s new foundation model for biomolecular structure, dynamics and function. Open weights, MIT license. github.com/microsoft/bioemu2 Movie: BioEmu2-simulated binding of intrinsically disordered peptide PUMA to MCL-1 receptor. 🧵⬇️
22
243
27
900
63,891
The Mo Lab discovers a new microbiome antibiotic and its mode of action: "Discovery and Characterization of Miranthins, "Trojan Horse" Antibiotic Modulators of Bacterial Composition in the Oral Microbiome,” in @PNASNews. Nice work Brielle, Brett, and Mo: doi.org/10.1073/pnas.2621138…
2
4
30
1,715